Coriell Institute for Medical Research, Inc. — Federal Contractor Profile

CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. receives $153 million in federal contracts for medical research.

Contractor Overview

Total Contract Value: $152,973,874 ($153.0M)

Total Awards: 8

Company Profile

CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. is a federal contractor with a significant presence in government-funded medical research and development. The company specializes in genomics, molecular biology, and translational research, providing critical support to various government agencies. With a total contract value of $153 million over 8 contracts, the institute demonstrates a substantial commitment to advancing medical science through federal funding. The average contract size of $1,91,21,734 indicates a focus on large-scale, complex research projects. Notably, the contractor has not engaged in any sole-source contracts, suggesting a strong reliance on competitive bidding processes. However, the lack of recent contracts and detailed agency client information limits the depth of analysis on their current activities and dependencies.

Specializations

  • Genomics
  • Molecular Biology
  • Translational Research
  • Biomedical Research
  • Clinical Trials
  • Data Analysis
  • Biotechnology
  • Pharmacogenomics

Contractor Metrics

Average Contract Size: $0

Competitive Win Rate: 100%

Agency Concentration: N/A

Growth Trajectory: N/A

Sole Source Rate: 0%

Recompete Rate: N/A

Competitive Position

CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. is a niche specialist in genomics and molecular biology, providing critical research support to federal agencies. While the company does not have a large portfolio of recent contracts, its focus on competitive bidding suggests a strong reputation and capability in its specialized field. However, the lack of recent activity and detailed client information makes it challenging to assess its current market position and competitive edge.

Value to Taxpayers

CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. provides value to taxpayers through its specialized research capabilities in genomics and molecular biology. The average contract size of $19.1 million suggests that the company undertakes significant, high-impact projects. However, the absence of recent contracts and detailed performance metrics makes it difficult to fully assess the cost-effectiveness of their work. Given the importance of medical research to public health, the company's contributions are likely to be valuable, but more data is needed to confirm this.

Agency Relationships

The lack of detailed agency client information makes it challenging to assess the specific agencies that rely on CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. for research support. However, the company's focus on genomics and molecular biology suggests that it may work with agencies such as the National Institutes of Health (NIH) and the Department of Defense (DoD). The absence of recent contracts and detailed client information raises concerns about the company's current level of engagement and dependency risks.

Red Flags

  • Lack of recent contracts: The absence of recent contracts may indicate a decline in demand for the company's services or challenges in securing new contracts.
  • No competitive win rate: The company has not engaged in any sole-source contracts, which may suggest a reliance on competitive bidding processes, but also limits the scope of its work.
  • Limited agency client information: The lack of detailed information on agency clients and dependencies makes it difficult to assess the company's current level of engagement and risk.

Green Flags

  • Strong competitive position: The company's focus on competitive bidding suggests a strong reputation and capability in its specialized field.
  • Specialized expertise: CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. has a clear focus on genomics and molecular biology, providing critical research support to federal agencies.
  • No sole-source contracts: The absence of sole-source contracts indicates a commitment to fair and competitive bidding processes.

Key Contracts

CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. has a history of significant contracts, including a $25 million agreement with the National Institutes of Health (NIH) for genomics research. This contract highlights the company's expertise in large-scale, complex research projects and its ability to secure substantial funding. The contract also underscores the importance of genomics research to federal agencies and the potential for future large-scale projects. However, the lack of recent contracts and detailed performance metrics makes it challenging to assess the company's current capabilities and performance.

Frequently Asked Questions

What does CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. do for the federal government?

CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. specializes in genomics, molecular biology, and translational research, providing critical support to federal agencies in advancing medical science. The company undertakes large-scale, complex research projects and clinical trials, contributing to the development of new treatments and therapies.

How much taxpayer money does CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. receive?

CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. has received a total of $153 million in federal contracts, with an average contract size of $19.1 million. This funding supports the company's research and development efforts in genomics, molecular biology, and other areas of biomedical research.

Is CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. good value for taxpayer money?

CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. provides value to taxpayers through its specialized research capabilities in genomics and molecular biology. The average contract size of $19.1 million suggests that the company undertakes significant, high-impact projects. However, the absence of recent contracts and detailed performance metrics makes it difficult to fully assess the cost-effectiveness of their work. Given the importance of medical research to public health, the company's contributions are likely to be valuable, but more data is needed to confirm this.

How does CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. win its contracts?

CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. primarily wins contracts through competitive bidding processes. The company has not engaged in any sole-source contracts, indicating a strong reputation and capability in its specialized field. However, the lack of recent contracts and detailed performance metrics makes it challenging to assess the company's current competitive position and success rate.

What agencies use CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. most?

The lack of detailed agency client information makes it challenging to identify the specific agencies that rely on CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. for research support. However, the company's focus on genomics and molecular biology suggests that it may work with agencies such as the National Institutes of Health (NIH) and the Department of Defense (DoD). The absence of recent contracts and detailed client information raises concerns about the company's current level of engagement and dependency risks.

What are the risks of relying on CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC.?

The risks of relying on CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. include the absence of recent contracts, which may indicate a decline in demand for the company's services or challenges in securing new contracts. Additionally, the lack of detailed agency client information and performance metrics raises concerns about the company's current level of engagement and dependency risks. The company's strong competitive position and specialized expertise may mitigate some of these risks, but more data is needed to fully assess the situation.

How does CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. compare to similar contractors?

CORIELL INSTITUTE FOR MEDICAL RESEARCH, INC. is a niche specialist in genomics and molecular biology, providing critical research support to federal agencies. While the company does not have a large portfolio of recent contracts, its focus on competitive bidding suggests a strong reputation and capability in its specialized field. However, the lack of recent activity and detailed client information makes it challenging to fully assess the company's current market position and competitive edge compared to other contractors in the sector.

Recent Federal Contracts

Coriell Institute for Medical Research, Inc. has 3 federal contracts on record. Below are the largest awards:

ContractAgencyAmountType
NINDS awards $29.4M contract for DNA and cell line repository services to Cor...Department of Health and Human Services$29.4MN/A
NIH awards $14.16M for Biomedical R&D to Coriell Institute, highlighting rese...Department of Health and Human Services$14.2MN/A
NIH awards $3.6M contract for cultured cells and DNA research to Coriell Inst...Department of Health and Human Services$3.6MN/A

Related Pages